Lyka Labs Limited (NSE:LYKALABS)
India · Delayed Price · Currency is INR 99.12
+0.22 (0.22%)
Sep 9, 2025, 9:29 AM IST
Lyka Labs Market Cap
Lyka Labs has a market cap or net worth of 3.53 billion as of September 8, 2025. Its market cap has decreased by -35.90% in one year.
Market Cap
3.53B
Enterprise Value
3.90B
Revenue
1.38B
Ranking
n/a
PE Ratio
48.02
Stock Price
99.12
Market Cap Chart
Since October 1, 2003, Lyka Labs's market cap has increased from 294.62M to 3.53B, an increase of 1,098.05%. That is a compound annual growth rate of 11.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 3.53B | -37.33% |
| Dec 31, 2024 | 5.63B | 37.55% |
| Dec 29, 2023 | 4.09B | 10.05% |
| Dec 30, 2022 | 3.72B | -41.66% |
| Dec 31, 2021 | 6.38B | 617.10% |
| Dec 31, 2020 | 889.39M | 58.16% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,823.58B |
| Divi's Laboratories | 1,595.20B |
| Cipla | 1,254.77B |
| Apollo Hospitals Enterprise | 1,122.17B |
| Mankind Pharma | 1,052.78B |
| Zydus Lifesciences | 1,020.17B |
| Fortis Healthcare | 715.59B |
| Alkem Laboratories | 637.70B |